Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Cancer ; 119(12): 2958-69, 2006 Dec 15.
Article in English | MEDLINE | ID: mdl-17019713

ABSTRACT

Agents that can modulate colonic environment and control dysregulated signaling are being evaluated for their chemopreventive potential in colon cancer. Ursodeoxycholate (UDCA) has shown chemopreventive potential in preclinical and animal models of colon cancer, but the mechanism behind it remains unknown. Here biological effects of UDCA were examined to understand mechanism behind its chemoprevention in colon cancer. Our data suggests that UDCA can suppress growth in a wide variety of cancer cell lines and can induce low level of apoptosis in colon cancer cells. We also found that UDCA treatment induces alteration in morphology, increased cell size, upregulation of cytokeratin 8, 18 and 19 and E-cadherin, cytokeratin remodeling and accumulation of lipid droplets, suggesting that UDCA induces differentiation in colon carcinoma cells. Our results also suggest significant differences in UDCA and sodium butyrate induced functional differentiation. We also report for the first time that UDCA can induce senescence in colon cancer cells as assessed by flattened, spread out and vacuolated morphology as well as by senescence marker beta-galactosidase staining. We also found that UDCA inhibits the telomerase activity. Surprisingly, we found that UDCA is not a histone deacytylase inhibitor but instead induces hypoacetylation of histones unlike hyperacetylation induced by sodium butyrate. Our results also suggest that, although UDCA induced senescence is p53, p21 and Rb independent, HDAC6 appears to be important in UDCA induced senescence. In summary, our data shows that UDCA modulates chromatin by inducing histone hypoacetylation and induces differentiation and senescence in colon cancer cells.


Subject(s)
Cell Differentiation/drug effects , Cellular Senescence/drug effects , Histones/metabolism , Ursodeoxycholic Acid/pharmacology , Acetylation/drug effects , Apoptosis/drug effects , Butyrates/pharmacology , Cadherins/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Shape/drug effects , Cell Size/drug effects , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Dose-Response Relationship, Drug , HCT116 Cells , HT29 Cells , Humans , Inhibitor of Apoptosis Proteins/metabolism , Keratin-18/metabolism , Keratin-19/metabolism , Keratin-8/metabolism , Retinoblastoma Protein/metabolism , Tumor Suppressor Protein p53/metabolism , Up-Regulation/drug effects
2.
BMC Cancer ; 6: 219, 2006 Sep 01.
Article in English | MEDLINE | ID: mdl-16948850

ABSTRACT

BACKGROUND: There is a large body of evidence which suggests that bile acids increase the risk of colon cancer and act as tumor promoters, however, the mechanism(s) of bile acids mediated tumorigenesis is not clear. Previously we showed that deoxycholic acid (DCA), a tumorogenic bile acid, and ursodeoxycholic acid (UDCA), a putative chemopreventive agent, exhibited distinct biological effects, yet appeared to act on some of the same signaling molecules. The present study was carried out to determine whether there is overlap in signaling pathways activated by tumorogenic bile acid DCA and chemopreventive bile acid UDCA. METHODS: To determine whether there was an overlap in activation of signaling pathways by DCA and UDCA, we mutagenized HCT116 cells and then isolated cell lines resistant to UDCA induced growth arrest. These lines were then tested for their response to DCA induced apoptosis. RESULTS: We found that a majority of the cell lines resistant to UDCA-induced growth arrest were also resistant to DCA-induced apoptosis, implying an overlap in DCA and UDCA mediated signaling. Moreover, the cell lines which were the most resistant to DCA-induced apoptosis also exhibited a greater capacity for anchorage independent growth. CONCLUSION: We conclude that UDCA and DCA have overlapping signaling activities and that disregulation of these pathways can lead to a more advanced neoplastic phenotype.


Subject(s)
Apoptosis/drug effects , Cell Proliferation/drug effects , Deoxycholic Acid/pharmacology , Drug Resistance, Neoplasm , Neoplasms/prevention & control , Ursodeoxycholic Acid/pharmacology , Antineoplastic Agents/pharmacology , Bile Acids and Salts/pharmacology , Cell Adhesion/drug effects , Drug Resistance, Neoplasm/physiology , HCT116 Cells , Humans , Mutagenicity Tests , Poly(ADP-ribose) Polymerases/metabolism
3.
J Biol Chem ; 281(21): 14948-60, 2006 May 26.
Article in English | MEDLINE | ID: mdl-16547009

ABSTRACT

Secondary bile acids have long been postulated to be tumor promoters in the colon; however, their mechanism of action remains unclear. In this study, we examined the actions of bile acids at the cell membrane and found that they can perturb membrane structure by alteration of membrane microdomains. Depletion of membrane cholesterol by treating with methyl-beta-cyclodextrin suppressed deoxycholic acid (DCA)-induced apoptosis, and staining for cholesterol with filipin showed that DCA caused a marked rearrangement of this lipid in the membrane. Likewise, DCA was found to affect membrane distribution of caveolin-1, a marker protein that is enriched in caveolae membrane microdomains. Additionally, fluorescence anisotropy revealed that DCA causes a decrease in membrane fluidity consistent with the increase in membrane cholesterol content observed after 4 h of DCA treatment of HCT116 cells. Significantly, by using radiolabeled bile acids, we found that bile acids are able to interact with and localize to microdomains differently depending on their physicochemical properties. DCA was also found to induce tyrosine phosphorylation and activate the receptor tyrosine kinase epidermal growth factor receptor in a ligand-independent manner. In contrast, ursodeoxycholic acid did not exhibit any of these effects even though it interacted significantly with the microdomains. Collectively, these data suggest that bile acid-induced signaling is initiated through alterations of the plasma membrane structure and the redistribution of cholesterol.


Subject(s)
Cell Membrane/metabolism , Deoxycholic Acid/chemistry , Signal Transduction , Apoptosis , Bile Acids and Salts/chemistry , Caveolin 1/metabolism , Cell Membrane/drug effects , Ceramides/chemistry , Cholesterol/metabolism , Detergents/pharmacology , Humans , Lipids/chemistry , Time Factors , Ursodeoxycholic Acid/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...